Literature DB >> 21176973

Peptide reactivity between multiple sclerosis (MS) CSF IgG and recombinant antibodies generated from clonally expanded plasma cells in MS CSF.

Xiaoli Yu1, Don Gilden, Laura Schambers, Olga Barmina, Mark Burgoon, Jeffrey Bennett, Greg Owens.   

Abstract

We employed 19 recombinant antibodies (rAbs) generated from clonally expanded plasma cells, and native IgG from cerebrospinal fluid (CSF) of three multiple sclerosis (MS) patients for panning with phage displayed random peptide libraries. Specific peptide epitopes/mimotopes were identified and characterized. Importantly, peptide-antibody interactions were shared by rAbs and native IgG from the same patient. Three peptides strongly interacted with at least one other MS CSF, but not to inflammatory CNS controls. Database searches revealed several protein candidates including stress proteins, cell surface proteins, and neuronal proteins. Peptides derived from the candidate proteins were recognized by rAbs. Identification of peptide epitopes/mimotopes in MS may provide clues regarding disease-relevant antigens.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21176973      PMCID: PMC3277395          DOI: 10.1016/j.jneuroim.2010.11.007

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  40 in total

1.  Single-cell repertoire analysis demonstrates that clonal expansion is a prominent feature of the B cell response in multiple sclerosis cerebrospinal fluid.

Authors:  Gregory P Owens; Alanna M Ritchie; Mark P Burgoon; R Anthony Williamson; John R Corboy; Donald H Gilden
Journal:  J Immunol       Date:  2003-09-01       Impact factor: 5.422

2.  Searching for peptide ligands with an epitope library.

Authors:  J K Scott; G P Smith
Journal:  Science       Date:  1990-07-27       Impact factor: 47.728

3.  Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study.

Authors:  M Reindl; C Linington; U Brehm; R Egg; E Dilitz; F Deisenhammer; W Poewe; T Berger
Journal:  Brain       Date:  1999-11       Impact factor: 13.501

4.  Myelin basic protein-reactive autoantibodies in the serum and cerebrospinal fluid of multiple sclerosis patients are characterized by low-affinity interactions.

Authors:  Kevin C O'Connor; Tanuja Chitnis; Diane E Griffin; Sucheep Piyasirisilp; Amit Bar-Or; Samia Khoury; Kai W Wucherpfennig; David A Hafler
Journal:  J Neuroimmunol       Date:  2003-03       Impact factor: 3.478

5.  Isolation and characterization of an oligodendrocyte precursor-derived B-cell epitope in multiple sclerosis.

Authors:  J J Archelos; J Trotter; S Previtali; B Weissbrich; K V Toyka; H P Hartung
Journal:  Ann Neurol       Date:  1998-01       Impact factor: 10.422

6.  Clonally expanded plasma cells in the cerebrospinal fluid of patients with central nervous system autoimmune demyelination produce "oligoclonal bands".

Authors:  Hans-Christian von Büdingen; Monica Gulati; Sandra Kuenzle; Katja Fischer; Tobias A Rupprecht; Norbert Goebels
Journal:  J Neuroimmunol       Date:  2009-11-08       Impact factor: 3.478

7.  Identification of peptides specific for cerebrospinal fluid antibodies in multiple sclerosis by using phage libraries.

Authors:  I Cortese; R Tafi; L M Grimaldi; G Martino; A Nicosia; R Cortese
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

8.  Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event.

Authors:  Thomas Berger; Paul Rubner; Franz Schautzer; Robert Egg; Hanno Ulmer; Irmgard Mayringer; Erika Dilitz; Florian Deisenhammer; Markus Reindl
Journal:  N Engl J Med       Date:  2003-07-10       Impact factor: 91.245

9.  Similar low frequency of anti-MOG IgG and IgM in MS patients and healthy subjects.

Authors:  V Lampasona; D Franciotta; R Furlan; S Zanaboni; R Fazio; E Bonifacio; G Comi; G Martino
Journal:  Neurology       Date:  2004-06-08       Impact factor: 9.910

10.  Comparative analysis of the CD19+ and CD138+ cell antibody repertoires in the cerebrospinal fluid of patients with multiple sclerosis.

Authors:  Alanna M Ritchie; Donald H Gilden; R Anthony Williamson; Mark P Burgoon; Xiaoli Yu; Karen Helm; John R Corboy; Gregory P Owens
Journal:  J Immunol       Date:  2004-07-01       Impact factor: 5.422

View more
  10 in total

1.  Intrathecally synthesized IgG in multiple sclerosis cerebrospinal fluid recognizes identical epitopes over time.

Authors:  Xiaoli Yu; Mark Burgoon; Miyoko Green; Olga Barmina; Kathryn Dennison; Tiffany Pointon; Molly Davis; Don Gilden
Journal:  J Neuroimmunol       Date:  2011-11-12       Impact factor: 3.478

2.  Identification of peptide targets in neuromyelitis optica.

Authors:  Xiaoli Yu; Miyoko Green; Don Gilden; Chiwah Lam; Katherine Bautista; Jeffrey L Bennett
Journal:  J Neuroimmunol       Date:  2011-05-28       Impact factor: 3.478

3.  Diagnostic strategy used to establish etiologies of encephalitis in a prospective cohort of patients in England.

Authors:  H E Ambrose; J Granerod; J P Clewley; N W S Davies; G Keir; R Cunningham; M Zuckerman; K J Mutton; K N Ward; S Ijaz; N S Crowcroft; D W G Brown
Journal:  J Clin Microbiol       Date:  2011-08-24       Impact factor: 5.948

4.  Glioblastoma Extracellular Vesicle-Specific Peptides Inhibit EV-Induced Neuronal Cytotoxicity.

Authors:  Wenbo Zhou; Julia Craft; Alex Ojemann; Luke Bergen; Arin Graner; Aitana Gonzales; Qianbin He; Timothy Kopper; Marie Smith; Michael W Graner; Xiaoli Yu
Journal:  Int J Mol Sci       Date:  2022-06-28       Impact factor: 6.208

5.  Protein array-based profiling of CSF identifies RBPJ as an autoantigen in multiple sclerosis.

Authors:  Luis Querol; Pamela L Clark; Mary A Bailey; Chris Cotsapas; Anne H Cross; David A Hafler; Steven H Kleinstein; Jae-Yun Lee; Gur Yaari; Simon N Willis; Kevin C O'Connor
Journal:  Neurology       Date:  2013-08-06       Impact factor: 9.910

6.  High-Density Peptide Microarray Analysis of IgG Autoantibody Reactivities in Serum and Cerebrospinal Fluid of Multiple Sclerosis Patients.

Authors:  Michael Hecker; Brit Fitzner; Matthias Wendt; Peter Lorenz; Kristin Flechtner; Felix Steinbeck; Ina Schröder; Hans-Jürgen Thiesen; Uwe Klaus Zettl
Journal:  Mol Cell Proteomics       Date:  2016-02-01       Impact factor: 5.911

7.  Aberrant Immunoglobulin G Glycosylation in Multiple Sclerosis.

Authors:  Peter G E Kennedy; Michael Graner; Tiffany Pointon; Xiaomeng Li; Kayo Tanimoto; Kathryn Dennison; Gina Im; Anthony Fringuello; Wenbo Zhou; Arin Graner; Stefan Sillau; Timothy Vollmer; Xiaoli Yu
Journal:  J Neuroimmune Pharmacol       Date:  2021-05-03       Impact factor: 7.285

8.  Identification of novel non-myelin biomarkers in multiple sclerosis using an improved phage-display approach.

Authors:  Andrea Cortini; Sara Bembich; Lorena Marson; Eleonora Cocco; Paolo Edomi
Journal:  PLoS One       Date:  2019-12-05       Impact factor: 3.240

9.  Brain Antigens Stimulate Proliferation of T Lymphocytes With a Pathogenic Phenotype in Multiple Sclerosis Patients.

Authors:  Assaf Gottlieb; Hoai Phuong T Pham; John William Lindsey
Journal:  Front Immunol       Date:  2022-01-31       Impact factor: 7.561

10.  Antibodies from Multiple Sclerosis Brain Identified Epstein-Barr Virus Nuclear Antigen 1 & 2 Epitopes which Are Recognized by Oligoclonal Bands.

Authors:  Michael W Graner; Xiaoli Yu; Zhe Wang; Peter Ge Kennedy; Cecily Dupree; Min Wang; Catherin Lee; Tiffany Pointon; T Dianne Langford
Journal:  J Neuroimmune Pharmacol       Date:  2020-08-18       Impact factor: 4.147

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.